Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration has approved India-based Orchid Chemicals & Pharmaceuticals' abbreviated new drug application (ANDA) for Venlafaxine extended release (ER) capsules.
Subscribe to our email newsletter
The drug has been given approval for its 37.5mg, 75mg and 150mg dosage strengths.
Venlafaxine ER capsules are indicated for the treatment of major depressive disorder (MDD) and social anxiety disorder.
Orchid has presence across segments like anti-infectives, anti-inflammatory, central nervous system (CNS), cadio vascular segment (CVS), nutraceuticals and other oral and sterile products.